Merck
US Director, Payor & Access Strategy Lead, Medical Affairs - Health Systems
Merck, Cheyenne, Wyoming, United States, 82007
Merck US Director, Payor & Access Strategy Lead, Medical Affairs - Health Systems Cheyenne, Wyoming Apply Now
The US Director, Payor and Access Strategy Lead, Medical Affairs (DPASL) is responsible for regional Field Medical (FM) strategy, training, and prioritization of the Value & Implementation (V&I) plan for USMA Health Systems (HS). The DPASL for health systems is an impactful member of the US Medical Affairs (ISMA) functional teams, US Regional Medical Affairs Teams (RMAT), US Value Teams (VT), and Field Leadership teams. The US DPASL drives strategic excellence and optimizes HD Field Team readiness in support of clinical and pharmacoeconomic scientific exchange aligned to Global V&I plan priorities. This is a regionally based position (US) in our Research and Development (R&D) division. Responsibilities and Primary Activities Responsible for the direction, coordination, implementation, control, and execution of Health Systems strategy while remaining aligned to global medical and commercial strategy, commitments, and goals. Leads the US HS integrated Field Medical (FM) plan process in collaboration with US HS Executive Director (US HS ED), US HS Senior PASL, US HS Team Leads, and Global Scientific Content - Health Systems (GSC-HS) team members. Possesses relevant medical affairs and Field Medical or clinical experience to guide and direct FM HS strategy in alignment with organizational priorities and unmet needs. Collects, analyzes, and communicates scientific insights from US HS Medical Affairs Director (MAD) field engagements to inform company strategies across the Value & Implementation organization, which includes GMSA and Outcomes Research (OR), and Commercial; develops listening priorities and updates them quarterly. Serves as US Health Systems interface between GMSA, Commercial, and other relevant headquarters (HQ) functions and the US HS MAD field team. Identifies and prioritizes US HS field resources, training needs, and activities across the portfolio, in collaboration with the GSVC-HS directors, to optimize HS MAD field team readiness. Collaborates with key stakeholders to define/implement strategic congress priorities for US HS and coordinates planning of HS MAD activities at key scientific congresses. Continuously scans the healthcare environment and quality landscape to analyze emerging trends in the therapeutic and competitive landscape, in addition to market access to optimize US Field HS Team capabilities. Represents USMA HS, in partnership with GMSA, in Expert Input Forums or Advisory Boards, as needed. Required Qualifications, Skills, & Experience- Minimum: Advanced healthcare/science degree (MD, PhD, or PharmD). Minimum of 5 years cumulative experience in both pharmaceutical industry, (preferably Field Medical experience or equivalent biotech/pharmaceutical/Medical Affairs strategy experience) AND working in quality/managed care, with demonstrated scientific acumen. Demonstrated ability to create and implement a strategic roadmap. Excellent interpersonal, communication, networking, and results-oriented project management skills. Thorough knowledge of clinical medicine, US healthcare delivery system structure and function, pharmaco-economics, population health management, quality management, value-based payment, and healthcare delivery policy and trends. Demonstrated ability to effectively work in a complex, matrixed environment (promoting inclusion, maintaining trust, and respecting others). Ability to network and partner with important internal and external stakeholders, including cross functional teams, scientific leaders, and key decision makers. Knowledge of national and society treatment guidelines, clinical research processes, FDA regulations, and Office of the Inspector General (OIG), Health Insurance Portability and Accountability Act (HIPAA), and other ethical guidelines, laws, and regulations relevant to the pharmaceutical industry and its external stakeholder environment. Preferred Prior experience leading complex projects with demonstrated ability to handle multiple projects and priorities simultaneously and function in a fast-paced environment. Formal training in pharmaco-economics/outcomes research.
#J-18808-Ljbffr
The US Director, Payor and Access Strategy Lead, Medical Affairs (DPASL) is responsible for regional Field Medical (FM) strategy, training, and prioritization of the Value & Implementation (V&I) plan for USMA Health Systems (HS). The DPASL for health systems is an impactful member of the US Medical Affairs (ISMA) functional teams, US Regional Medical Affairs Teams (RMAT), US Value Teams (VT), and Field Leadership teams. The US DPASL drives strategic excellence and optimizes HD Field Team readiness in support of clinical and pharmacoeconomic scientific exchange aligned to Global V&I plan priorities. This is a regionally based position (US) in our Research and Development (R&D) division. Responsibilities and Primary Activities Responsible for the direction, coordination, implementation, control, and execution of Health Systems strategy while remaining aligned to global medical and commercial strategy, commitments, and goals. Leads the US HS integrated Field Medical (FM) plan process in collaboration with US HS Executive Director (US HS ED), US HS Senior PASL, US HS Team Leads, and Global Scientific Content - Health Systems (GSC-HS) team members. Possesses relevant medical affairs and Field Medical or clinical experience to guide and direct FM HS strategy in alignment with organizational priorities and unmet needs. Collects, analyzes, and communicates scientific insights from US HS Medical Affairs Director (MAD) field engagements to inform company strategies across the Value & Implementation organization, which includes GMSA and Outcomes Research (OR), and Commercial; develops listening priorities and updates them quarterly. Serves as US Health Systems interface between GMSA, Commercial, and other relevant headquarters (HQ) functions and the US HS MAD field team. Identifies and prioritizes US HS field resources, training needs, and activities across the portfolio, in collaboration with the GSVC-HS directors, to optimize HS MAD field team readiness. Collaborates with key stakeholders to define/implement strategic congress priorities for US HS and coordinates planning of HS MAD activities at key scientific congresses. Continuously scans the healthcare environment and quality landscape to analyze emerging trends in the therapeutic and competitive landscape, in addition to market access to optimize US Field HS Team capabilities. Represents USMA HS, in partnership with GMSA, in Expert Input Forums or Advisory Boards, as needed. Required Qualifications, Skills, & Experience- Minimum: Advanced healthcare/science degree (MD, PhD, or PharmD). Minimum of 5 years cumulative experience in both pharmaceutical industry, (preferably Field Medical experience or equivalent biotech/pharmaceutical/Medical Affairs strategy experience) AND working in quality/managed care, with demonstrated scientific acumen. Demonstrated ability to create and implement a strategic roadmap. Excellent interpersonal, communication, networking, and results-oriented project management skills. Thorough knowledge of clinical medicine, US healthcare delivery system structure and function, pharmaco-economics, population health management, quality management, value-based payment, and healthcare delivery policy and trends. Demonstrated ability to effectively work in a complex, matrixed environment (promoting inclusion, maintaining trust, and respecting others). Ability to network and partner with important internal and external stakeholders, including cross functional teams, scientific leaders, and key decision makers. Knowledge of national and society treatment guidelines, clinical research processes, FDA regulations, and Office of the Inspector General (OIG), Health Insurance Portability and Accountability Act (HIPAA), and other ethical guidelines, laws, and regulations relevant to the pharmaceutical industry and its external stakeholder environment. Preferred Prior experience leading complex projects with demonstrated ability to handle multiple projects and priorities simultaneously and function in a fast-paced environment. Formal training in pharmaco-economics/outcomes research.
#J-18808-Ljbffr